BUSPIRONE IN THE TREATMENT OF POSTTRAUMATIC-STRESS-DISORDER

被引：0
|
作者：
WELLS, BG
CHU, CC
JOHNSON, R
NASDAHL, C
AYUBI, MA
SEWELL, E
STATHAM, P
机构：
[1] UNIV TENNESSEE,CTR HLTH SCI,DEPT CLIN PHARM,MEMPHIS,TN 38163
[2] UNIV TENNESSEE,CTR HLTH SCI,DEPT PSYCHIAT,MEMPHIS,TN 38163
来源：
PHARMACOTHERAPY | 1991年 / 11卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Three patients with a DSM-III-R diagnosis of posttraumatic stress disorder were successfully treated with buspirone in final maximum dosages ranging from 35-60 mg daily. The onset of clinical efficacy ranged from 5-29 days. Symptoms that improved included anxiety, insomnia, flashbacks, and depressed mood. Patients experienced no side effects. Serotonin partial agonist effects are a possible mechanism underlying buspirone's efficacy.
引用
收藏
页码：340 / 343
页数：4
相关论文
共 50 条
12345